CLINICAL STUDIES
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications
Wayne B. Batchelor, MD*,
Eric D. Peterson, MD, MPH*,
Daniel B. Mark, MD, MPH, FACC*,
J. David Knight, MS*,
Christopher B. Granger, MD, FACC*,
Paul W. Armstrong, MD, FACC and
Robert M. Califf, MD, FACC*
* Duke University Clinical Research Institute, Durham, North Carolina, USA
Walter C. Mackenzie Health Sciences Center, Edmonton, Alberta, Canada
Manuscript received September 8, 1998;
revised manuscript received January 27, 1999,
accepted March 26, 1999.
Reprint requests and correspondence: Dr. Eric D. Peterson, Box 3236, Duke University Medical Center, Durham, North Carolina 27710
Peter012{at}mc.duke.edu
OBJECTIVES
We sought to compare U.S. and Canada’s post-myocardial infarction (MI) cardiac catheterization practices in the detection of severe coronary artery disease (CAD).
BACKGROUND
Little is known about the efficiency with which the aggressive post-MI catheterization strategy observed in the U.S. detects severe CAD compared with the more conservative strategy observed in Canada.
METHODS
From the U.S. and Canadian patients who had participated in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries trial (n = 22,280, 11.5% Canadian), we examined the frequency of in-hospital cardiac catheterization, the prevalence of severe CAD observed at catheterization (diagnostic efficiency) and the total number of MI patients with severe CAD identified (diagnostic yield).
RESULTS
The rate of catheterization in the U.S. was more than 2.5 times that in Canada (71% vs. 27%, respectively, p < 0.001). With identical prevalences of severe CAD at catheterization (17%) in the two countries, the higher frequency of catheterization in the U.S. resulted in the identification of more than two and a half times as many cases of severe CAD compared with Canada (12 severe CAD cases identified per 100 post-MI patients in the U.S., vs. 4.6 per 100 in Canada). If considered in isolation, we estimated that these differences in severe disease detection might effect a small long-term survival advantage in favor of the U.S. strategy (estimated 5.0 lives saved per 1,000 MI patients).
CONCLUSIONS
Canada’s more restrictive post-MI cardiac catheterization strategy is no more efficient in identifying severe CAD than the aggressive U.S. strategy, and may fail to identify a substantial number of post-MI patients with high risk coronary anatomy. The long-term impact of these differences in practice patterns requires further evaluation.
|
Abbreviations and Acronyms
| | CAD | = coronary artery disease | | CI | = confidence interval | | GUSTO-1 | = Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries | | LMD | = left main coronary disease | | MI | = myocardial infarction | | 3VD | = three-vessel coronary disease |
|
This article has been cited by other articles:
|
|
|
|
 
S. M. Singh, P. C. Austin, A. Chong, and D. A. Alter
Coronary Angiography Following Acute Myocardial Infarction in Ontario, Canada
Arch Intern Med,
April 23, 2007;
167(8):
808 - 813.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Z. Ayanian
Rising Rates of Cardiac Procedures in the United States and Canada: Too Much of a Good Thing?
Circulation,
January 24, 2006;
113(3):
333 - 335.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Graham, W. A. Ghali, P. D. Faris, P. D. Galbraith, J. V. Tu, C. M. Norris, A. Zentner, M. L. Knudtson, and for the APPROACH Investigators
Population rates of cardiac catheterization and yield of high-risk coronary artery disease
Can. Med. Assoc. J.,
July 5, 2005;
173(1):
35 - 39.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-C. Chang, W. K Midodzi, C. M Westerhout, E. Boersma, J. Cooper, E. S Barnathan, M. L Simoons, L. Wallentin, E M. Ohman, P. W Armstrong, et al.
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis
J Epidemiol Community Health,
May 1, 2005;
59(5):
427 - 433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Alter, J. V. Tu, P. C. Austin, and C. D. Naylor
Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada
J. Am. Coll. Cardiol.,
August 6, 2003;
42(3):
410 - 419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. L. Dauerman
The early days after ST-segment elevation acute myocardial infarction: Reconsidering the delayed invasive approach
J. Am. Coll. Cardiol.,
August 6, 2003;
42(3):
420 - 423.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. D. Peterson, C. V. Pollack Jr, M. T. Roe, L. S. Parsons, K. A. Littrell, J. G. Canto, H. V. Barron, and National Registry of Myocardial Infarction (NRMI)
Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: Observations from the National Registry of Myocardial Infarction 4
J. Am. Coll. Cardiol.,
July 2, 2003;
42(1):
45 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. W. Klarenbach and P. Jacobs
International Comparison of Health Resource Utilization in Subjects With Diabetes: An analysis of Canadian and American national health surveys
Diabetes Care,
April 1, 2003;
26(4):
1116 - 1122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Califf and D. L. DeMets
Principles From Clinical Trials Relevant to Clinical Practice: Part I
Circulation,
August 20, 2002;
106(8):
1015 - 1021.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Llevadot, R.P Giugliano, E.M Antman, R.G Wilcox, E.P Gurfinkel, T Henry, C.H McCabe, A Charlesworth, S Thompson, J.C Nicolau, et al.
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction
Eur. Heart J.,
November 2, 2001;
22(22):
2104 - 2115.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R.P Giugliano, J Llevadot, R.G Wilcox, E.P Gurfinkel, C.H McCabe, A Charlesworth, S.L Thompson, E.M Antman, E Braunwald, and for the In TIME II Investigators
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II
Eur. Heart J.,
September 2, 2001;
22(18):
1702 - 1715.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. A. Alter, C. D. Naylor, P. C. Austin, and J. V. Tu
Long-term MI Outcomes at Hospitals With or Without On-site Revascularization
JAMA,
April 25, 2001;
285(16):
2101 - 2108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.C. O'Shea and R.M. Calif
Inter-regional differences in acute coronary syndrome trials
Eur. Heart J.,
September 1, 2000;
21(17):
1397 - 1399.
[PDF]
|
|
|
|
|
|
|
S.T. Higano and B.J. Gersh
Coronary angiography and outcome following acute myocardial infarction
Eur. Heart J.,
May 1, 2000;
21(9):
707 - 709.
[PDF]
|
|
|
|
|
|
|
To Cath or Not to Cath After MI
Journal Watch Cardiology,
September 16, 1999;
1999(916):
8 - 8.
[Full Text]
|
|
|
|
